This study aims to evaluate the median survival rates of patients hospitalized for heart failure with reduced ejection fraction who were prescribed quadruple medical therapy.
Patients hospitalized for heart failure with reduced ejection fraction were analyzed.
Quadruple medical therapy was administered to assess its impact on survival rates.
Survival analysis was performed to determine median survival times.
The median survival rate among patients receiving quadruple therapy was significantly improved compared to standard care.
Survival analysis indicated an increased survival rate with a hazard ratio of 0.65, 95% CI [0.50-0.85], p=0.002.
Improved clinical outcomes were associated with the introduction of quadruple medical therapy.